Bio-Techne
TECH
281 hedge funds and large institutions have $3.7B invested in Bio-Techne in 2016 Q4 according to their latest regulatory filings, with 23 funds opening new positions, 100 increasing their positions, 106 reducing their positions, and 31 closing their positions.
385.97% more ownership
Funds ownership: 0% → 385.97% (+386%)
6% less repeat investments, than reductions
Existing positions increased: 100 | Existing positions reduced: 106
4% less funds holding
Funds holding: 293 → 281 (-12)
5% less capital invested
Capital invested by funds: $3.91B → $3.7B (-$204M)
26% less first-time investments, than exits
New positions opened: 23 | Existing positions closed: 31
33% less funds holding in top 10
Funds holding in top 10: 3 → 2 (-1)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
O
OppenheimerFunds
New York
|
+$23.3M |
| 2 |
DDC
DF Dent & Co
Baltimore,
Maryland
|
+$12.1M |
| 3 |
Neuberger Berman Group
New York
|
+$10.2M |
| 4 |
JSP
Jackson Square Partners
Larkspur,
California
|
+$9.87M |
| 5 |
Massachusetts Financial Services
Boston,
Massachusetts
|
+$8.79M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
First Trust Advisors
Wheaton,
Illinois
|
-$16.5M |
| 2 |
Northern Trust
Chicago,
Illinois
|
-$13.2M |
| 3 |
Lord, Abbett & Co
Jersey City,
New Jersey
|
-$10.2M |
| 4 |
Two Sigma Investments
New York
|
-$8.55M |
| 5 |
Millennium Management
New York
|
-$7.47M |
TECH Hedge Fund Activity: Q4 2016 in Review
281 of the 4,000 institutional investors tracked by Wall St. Rank reported a position in Bio-Techne (TECH) for Q4 2016, worth a combined $3.7B — down 5.2% from $3.91B a quarter earlier.
Sellers outnumbered buyers: 31 funds closed out of TECH and 23 opened new positions — a net loss of 8 holders — while 106 trimmed existing stakes and 100 added.
The largest buyer was OppenheimerFunds, opening a new position worth an estimated $23.3M. The largest seller was First Trust Advisors, cutting an estimated $16.5M.
- 281 institutional investors held Bio-Techne (TECH) as of Q4 2016, down from 293 in Q3 2016.
- Funds reported $3.7B of Bio-Techne stock for Q4 2016, down 5.2% quarter-over-quarter.
- 23 funds opened new Bio-Techne positions in Q4 2016 and 31 closed out, a net change of -8 holders.
- The largest Bio-Techne buyer in Q4 2016 was OppenheimerFunds, an estimated $23.3M added.
- The largest Bio-Techne seller in Q4 2016 was First Trust Advisors, an estimated $16.5M sold.
Based on aggregated 13F filings for Q4 2016.